# An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients

> **NCT03619187** · PHASE3 · WITHDRAWN · sponsor: **Amgen**

## Conditions studied

- Heart Transplantation, Elevated Resting Heart Rate

## Interventions

- **DRUG:** Ivabradine

## Key facts

- **NCT ID:** NCT03619187
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-11-02
- **Primary completion:** 2020-02-19
- **Final completion:** 2020-02-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2018-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03619187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03619187, "An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03619187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*